Clinical Trial Update: Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

View source ↗

Summary

A post-marketing surveillance study of docetaxel-based chemotherapy in non-small cell lung cancer and head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Nonsmall Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Status: COMPLETED